But when you look at the scope of the problem and how many people are being treated appropriately, theres still a lot of room for growth and improvement. Novo is in a race for the obesity and weight-management market, the next big prize, and its got a good head start: The approval of Wegovy in 2021 was the first for a weight-loss drug since 2014
Imagine a future where we can harness the protective properties of glutathione to shield our stomachs from various insults
However, the popularity of these medications has led to drug shortages, so some pharmacies make custom-made versions of semaglutide called compounded semaglutide, which are not FDA-approved
Follow-up visits are not required for all patients, but are available if needed
These medications are indicated for diabetes and the long-term treatment of obesity
Hypoglycemia (Low Blood Sugar): The risk is low when GLP-1s are used alone but increases significantly when they are combined with other diabetes medications like insulin or sulfonylureas